Clinical Trial

Reduced-dose vs Standard-dose Irradiation for Low-risk Clinical Target Volume in Nasopharyngeal Carcinoma.

Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
To evaluate the locoregional control, survival rate, toxicity, and quality of life in patients with nasopharyngeal carcinoma treated with reduced prophylactic irradiation doses to the Low-Risk Clinical Target Volume (CTV).
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-09-23; most recent amendment 2026-03-31.
Status change: Not Yet Recruiting → Recruiting 2025-11-13
Trial Details
NCT Number NCT07201337
Lead Sponsor Sun Yat-sen University
Collaborators: Cancer Hospital Chinese Academy of Medical Science, Shenzhen Center, Affiliated Hospital of Guangdong Medical University, The University of Hong Kong-Shenzhen Hospital, Dongguan People's Hospital, Affiliated Cancer Hospital of Shantou University Medical College
Conditions Nasopharyngeal Cancinoma (NPC)
Enrollment 700 participants
Start Date 2025-11-17
Primary Completion 2029-11-17 (estimated)
Study Completion 2031-11-17 (estimated)
Updated on ClinicalTrials.gov 2026-04-06